Abstract:BACKGROUND & AIMS: <AbstractText Label="BACKGROUND &amp; AIMS" NlmCategory="OBJECTIVE">This review was developed to provide a thorough and effective update on models relevant to esophageal metaplasia, dysplasia, and carcinogenesis, focusing on the advantages and limitations of different models of Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC).</AbstractText>METHODS: <AbstractText Label="METHODS" NlmCategory="METHODS">This expert review was written on the basis of a thorough review of the literature combined with expert interpretation of the state of the field. We emphasized advances over the years 2012-2023 and provided detailed information related to the characterization of established human esophageal cell lines.</AbstractText>RESULTS: <AbstractText Label="RESULTS" NlmCategory="RESULTS">New insights have been gained into the pathogenesis of BE and EAC using patient-derived samples and single-cell approaches. Relevant animal models include genetic as well as surgical mouse models and emphasize the development of lesions at the squamocolumnar junction in the mouse stomach. Rat models are generated using surgical approaches that directly connect the small intestine and esophagus. Large animal models have the advantage of including features in human esophagus such as esophageal submucosal glands. Alternatively, cell culture approaches remain important in the field and allow for personalized approaches, and scientific rigor can be ensured by authentication of cell lines.</AbstractText>CONCLUSIONS: <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Research in BE and EAC remains highly relevant given the morbidity and mortality associated with cancers of the tubular esophagus and gastroesophageal junction. Careful selection of models and inclusion of human samples whenever possible will ensure relevance to human health and disease.</AbstractText>

Recent insights into the biology of Barrett's esophagus

Molecular Mechanisms of Barrett’s Esophagus

Promises and Limitations of Current Models for Understanding Barrett’s Esophagus and Esophageal Adenocarcinoma

A Systematic Review and Meta-Analysis of the Treatment for Barrett’s Esophagus

Diagnostic and Predictive Biomarkers for Barrett’s Esophagus: a Narrative Review

[Barrett's Esophagus: Update on the Diagnosis and Treatment. Review]

Barrett's esophagus: A historical perspective, an update on core practicalities and predictions on future evolutions of management

The role of bile acids in the neoplastic progression of Barrett's esophagus - a short representative overview

Pathogenesis and Cells of Origin of Barrett's Esophagus

Advance of Study on Bile Acids in Barrett's Carcinogenesis

Barrett's Esophagus Risk Factors in Patients Without Gastroesophageal Reflux: A Large Population-Based Study

Molecular Evolution of Metaplasia to Adenocarcinoma in the Esophagus

Global Changes in Gene Expression of Barrett's Esophagus Compared to Normal Squamous Esophagus and Gastric Cardia Tissues.

Signaling Pathways in the Pathogenesis of Barrett's Esophagus and Esophageal Adenocarcinoma

Esophageal Adenocarcinoma Arising from Barrett'S Epithelium in Taiwan

The role of the fibroblast in Barrett's esophagus and esophageal adenocarcinoma

Progress of Study on Barrett Esophagus-related Diseases in China

Insights Into the Oral Microbiome and Barrett's Esophagus Early Detection: A Narrative Review

Origins of Metaplasia in the Esophagus: Is This a GE Junction Stem Cell Disease?

Current Status of Barrett's Esophagus Research in Asia

Acid, bile, and CDX: the ABCs of making Barrett's metaplasia